Age, Biography and Wiki
Michael Albeck was born on 19 October, 0034 in Berlin, Germany, is an Israeli chemist. Discover Michael Albeck's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 90 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
90 years old |
| Zodiac Sign |
Libra |
| Born |
19 October 0034 |
| Birthday |
19 October |
| Birthplace |
Berlin, Germany |
| Nationality |
Germany
|
We recommend you to check the complete list of Famous People born on 19 October.
He is a member of famous President with the age 90 years old group.
Michael Albeck Height, Weight & Measurements
At 90 years old, Michael Albeck height not available right now. We will update Michael Albeck's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Michael Albeck Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Michael Albeck worth at the age of 90 years old? Michael Albeck’s income source is mostly from being a successful President. He is from Germany. We have estimated Michael Albeck's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
President |
Michael Albeck Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Michael Albeck (Hebrew: מיכאל אלבק) (born October 1934) is an Israeli organic and bioorganic chemist of tellurium compounds.
Michael Albeck was born in Berlin, Germany to Hanoch and Henya Albeck in October 1934.
His family immigrated to Israel (then Mandatory Palestine) in 1935 and settled in Jerusalem.
He earned both MSc in Chemistry (1959) and PhD (1962) from The Hebrew University of Jerusalem.
He worked as Principal Investigator in the Institute for Fiber and Forest Products in Jerusalem in 1962-1964, as the head of the chemical laboratories of Mekorot Water Company in 1964-1965, and then he joined Bar Ilan University as a faculty member at the Department of Chemistry, becoming a Full Professor in 1978.
Albeck served as the Dean of The Faculty of Natural Sciences of Bar Ilan University twice (1967-1969 and 1972-1975), as a member of the Board of Governors and the Board of Trustees of the university (1982-1999) and as the university’s Rector (1982-1986) and President (1986-1989; succeeding Emanuel Rackman, and succeeded by Ernest Krausz).
He was President of Bar-Ilan University from 1986 to 1989.
Since 2003 he is a Professor Emeritus at Bar Ilan.
Albeck assumed many scientific duties outside Bar Ilan University, including member of the boards of The Weizmann Scientific Press, Dead Sea Works, The German-Israel Binational Foundation (GIF), Teva Pharmaceuticals, and as the President of The Israel Chemical Society.
Prof. Michael Albeck is the son of the late Prof. Hanoch Albeck, who was a Professor of Talmud at the Hebrew University of Jerusalem and one of the foremost scholars of Judaic studies.
Michael and his wife Shulamit, a retired Faculty member of the School of Social Work at Bar Ilan University, have four children, including chemistry professor Amnon Albeck, grandchildren and great grandchildren.
Albeck’s main scientific interests are in the chemistry
of organic and inorganic tellurium compounds.
Two of these compounds, AS101 and SAS, exhibit immuno-modulating, antiviral and anticancer activity.
They are now in various clinical trials.
He published over 120 scientific publications and patents.
